A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI)
Status:
Recruiting
Trial end date:
2022-12-22
Target enrollment:
Participant gender:
Summary
This study will be conducted to evaluate the therapeutic response of oral gepotidacin
compared to oral nitrofurantoin for uncomplicated UTI in adolescent and adult female
subjects. In this study, subjects will be randomly assigned in a 1:1 ratio to receive either
oral gepotidacin or oral nitrofurantoin. The study will enroll approximately 2000 subjects
with uncomplicated UTI. The duration of the study will be approximately 28 days.